Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Change in Accured Expenses (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Change in Accured Expenses for 8 consecutive years, with $412000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses changed N/A to $412000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$953000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$346000.0 for FY2025, 10.59% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $412000.0 at Actinium Pharmaceuticals, up from -$1.0 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $2.3 million in Q4 2022, with the low at -$2.8 million in Q1 2023.
  • Average Change in Accured Expenses over 5 years is $130588.2, with a median of -$196000.0 recorded in 2023.
  • The sharpest move saw Change in Accured Expenses soared 505.76% in 2022, then tumbled 907.27% in 2023.
  • Over 5 years, Change in Accured Expenses stood at $1.8 million in 2021, then increased by 28.39% to $2.3 million in 2022, then tumbled by 108.67% to -$196000.0 in 2023, then crashed by 911.22% to -$2.0 million in 2024, then skyrocketed by 120.79% to $412000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $412000.0, -$1.0 million, and -$2.0 million for Q4 2025, Q1 2025, and Q3 2024 respectively.